论文部分内容阅读
目的探讨胰岛素泵在糖尿病患者围手术期的应用效果及临床分析。方法 2011年5月至2012年5月期间,我院诊治的60例糖尿病患者,随机将其分为对照组(多次皮下胰岛素注射)和观察组(胰岛素泵),每组各30例,通过血糖监测仪,对两组空腹血糖,餐后2h血糖进行检测,对两组的血糖控制情况、血糖达标时间、胰岛素用量,以及低血糖的发生率等方面,进行观察和比较。结果与治疗前相比,治疗后两组患者的血糖都得到了有效控制。治疗后,与对照组相比,观察组的血糖控制情况没有明显改变,P>0.05,差异无统计学意义。与对照组相比(6.5±2.0)U,观察组血糖达标时间明显缩短(3.7±1.4)h,P<0.05;与对照组相比(45.5±7.0),观察组胰岛素用量显著减少(37.5±7.5)U,P<0.05;与对照组相比(23.3%),观察组低血糖发生率明显降低(3.3%),P<0.05。结论与传统胰岛素注射方法相比,胰岛素泵注射胰岛素,能够更好的控制血糖,缩短达标时间,减少胰岛素用量,降低低血糖的发生率,有利于患者的预后,值得临床推广。
Objective To investigate the effect and clinical analysis of perioperative application of insulin pump in diabetic patients. Methods From May 2011 to May 2012, 60 cases of diabetic patients diagnosed and treated in our hospital were randomly divided into control group (multiple subcutaneous insulin injection) and observation group (insulin pump), 30 cases in each group, Blood glucose monitor, the two groups of fasting blood glucose, 2h postprandial blood glucose test, the two groups of blood glucose control, blood glucose compliance time, the amount of insulin, and the incidence of hypoglycemia were observed and compared. Results Compared with those before treatment, the blood glucose in both groups was effectively controlled after treatment. After treatment, compared with the control group, the observation group’s blood glucose control did not change significantly, P> 0.05, the difference was not statistically significant. Compared with the control group (6.5 ± 2.0) U, the observed time of glycemic control in the observation group was significantly shorter (3.7 ± 1.4) h, P <0.05; compared with the control group (45.5 ± 7.0), the insulin dosage in the observation group was significantly reduced (37.5 ± 7.5) U, P <0.05; Compared with the control group (23.3%), the incidence of hypoglycemia in the observation group decreased significantly (3.3%), P <0.05. Conclusion Compared with the traditional insulin injection method, insulin pump injection of insulin can better control blood sugar, shorten the compliance time, reduce insulin dosage, reduce the incidence of hypoglycemia, is conducive to the prognosis of patients, is worthy of clinical promotion.